Physician profile
Whitney Smith
NPI 1518227867
$3,096.08
in general payments reported to CMS, 2019-2025
22 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $27.07 · 2022: $486 · 2023: $589 · 2024: $547 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,088 · Travel and Lodging: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,088.34 |
| Travel and Lodging | $341.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $720.09 | 2022-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $504.42 | 2022-2025 | Solyx Sis System, Axonics, Rezum Generator |
| Intuitive Surgical, INC. | $358.44 | 2022-2025 | |
| Axonics, INC. | $326.33 | 2020-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $213.30 | 2023-2025 | Gemtesa |
| Coloplast Corp | $154.35 | 2023-2025 | Altis |
| Convatec INC. | $146.83 | 2022-2025 | |
| Allergan, INC. | $134.62 | 2019 | |
| Procept Biorobotics Corporation | $110.29 | 2025 | |
| Teleflex LLC | $73.96 | 2023-2024 | Urolift |
| Urovant Sciences INC | $71.79 | 2022 | |
| Photocure INC | $46.76 | 2023 | Cysview |
| Palette Life Sciences, INC. | $39.79 | 2022 | |
| Hollister Incorporated | $28.78 | 2023 | Vapro Pocket, Infyna Chic |
| Janssen Biotech, INC. | $24.69 | 2024 | Erleada |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $23.86 | 2023 | Lofric |
| Urogen Pharma, INC. | $23.48 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $21.62 | 2023 | Lynparza |
| Astellas Pharma US INC | $20.23 | 2023 | Veozah |
| Medtronic USA, INC. | $18.21 | 2019 | |
| 180 Medical, INC. | $17.45 | 2023 | |
| Mission Pharmacal Company | $16.79 | 2023 | Uribel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.